Use of melatonin for the treatment of androgenetic alopecia
US6281241A · kind A · utility
13Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 18, 2000 |
| Grant date | Aug 28, 2001 |
| Priority date | — |
| Expiry date | Feb 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of melatonin and melatonin-containing preparations for the treatment of androgenetic alopecia of the female type.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.